Royal Bank of Canada Reiterates “Outperform” Rating for Elevance Health (NYSE:ELV)
Elevance Health (NYSE:ELV – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at Royal Bank of Canada in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $478.00 price target on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 24.28% […]
Elevance Health (NYSE:ELV – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at Royal Bank of Canada in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $478.00 price target on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 24.28% […]
